Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Parecoxib Sodium for Injection

Approval Number

国药准字H20223593

Company广东众生药业股份有限公司

Registration Date

August 10, 2022

Drug Information

Generic Name

注射用帕瑞昔布钠

Dosage Form

注射剂

Strength

40mg（按C₁₉H₁₈N₂O₄S计）

Drug Type

化学药品

Registration Date

August 10, 2022

Company Information

Applicant Company

Company Name广东众生药业股份有限公司

Company Address

广东省东莞市石龙镇西湖工业区信息产业园

Manufacturing Company

Company Name广东众生药业股份有限公司

Company Address

广东省东莞市石龙镇西湖工业区信息产业园

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy